CMPX FY 2019 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$764M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$34M

Net Income

-$35M

EPS (Diluted)

$-0.67

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$915,000

Balance Sheet

Total Assets

$30M

Total Liabilities

$149M

Stockholders' Equity

-$119M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$2M	+100.0%
Operating Income	-$34M	-$38M	+11.1%
Net Income	-$35M	-$38M	+9.3%